PRR20G

Chr 3

proline rich 20G

NCBI Gene: 100419008 ENSG00000239620 UniProt: P0DPQ3

I notice that no specific information about PRR20G has been provided in your request - there's no data about the protein function, associated diseases, inheritance patterns, or constraint metrics that you've instructed me to use exclusively. Without the supporting data that your strict rules require me to reference, I cannot write the clinical gene summary. Could you please provide the specific information about PRR20G (protein function, associated phenotypes, inheritance pattern, and any relevant clinical details) that should be included in the summary?

Research

ResearchGenerating clinical summary…

Multiplemechanism

Clinical Summary— PRR20G

Explore recent and relevant literature in Research Assistant →

Population Genetics & Constraint

gnomAD

Constraint data not available from gnomAD.

This gene — mechanism propensity

0.6453th %ile

GOF

0.74top 25%

LOF

0.2678th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.